Corrigendum to: “Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer” [Int. J. Biol Macromol. 245 (2023) Jun 21; 125510/Online ahead of print. PMID: 37353120; IJBIOMAC-D-23-03903R1](S0141813023024042)(10.1016/j.ijbiomac.2023.125510)

Kianpour M.Huang C.W.Vejvisithsakul P.P.Wang J.Y.Li C.F.Shiao M.S.Pan C.T.Shiue Y.L.Mahidol University2023-08-282023-08-282023-09-01International Journal of Biological Macromolecules Vol.248 (2023)01418130https://repository.li.mahidol.ac.th/handle/20.500.14594/88822The authors regret misassembled Fig. 3 while revising and providing a correct version of Fig. 3 in the attached file. The authors would like to apologize for any inconvenience caused. Please kindly help us with the corrigendum.[Formula presented]Biochemistry, Genetics and Molecular BiologyCorrigendum to: “Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer” [Int. J. Biol Macromol. 245 (2023) Jun 21; 125510/Online ahead of print. PMID: 37353120; IJBIOMAC-D-23-03903R1](S0141813023024042)(10.1016/j.ijbiomac.2023.125510)ErratumSCOPUS10.1016/j.ijbiomac.2023.1257822-s2.0-851680057251879000337481838